We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.99B
AUM Growth
+$284M
Cap. Flow
+$258M
Cap. Flow %
12.95%
Top 10 Hldgs %
13.22%
Holding
2,248
New
441
Increased
650
Reduced
654
Closed
492

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Consumer Discretionary 13.01%
3 Healthcare 12.59%
4 Industrials 12.57%
5 Financials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SID icon
1551
Companhia Siderúrgica Nacional
SID
$1.23B
$94K ﹤0.01%
+46,507
New +$110K
ATHN
1552
DELISTED
Athenahealth, Inc.
ATHN
$94K ﹤0.01%
+590
New +$87.5K
HMY icon
1553
Harmony Gold Mining
HMY
$10.3B
$93K ﹤0.01%
59,809
-67,678
-53% -$127K
LAMR icon
1554
Lamar Advertising Co
LAMR
$16B
$93K ﹤0.01%
1,365
+9
+0.7% +$603
LPL icon
1555
LG Display
LPL
$3.07B
$93K ﹤0.01%
11,236
-36,194
-76% -$380K
USX
1556
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$93K ﹤0.01%
+6,175
New +$93K
ESIO
1557
DELISTED
Electro Scientific Industries
ESIO
$93K ﹤0.01%
+5,900
New +$111K
BKD icon
1558
Brookdale Senior Living
BKD
$3.43B
$92K ﹤0.01%
10,100
-143,733
-93% -$1.12M
MGTX icon
1559
MeiraGTx Holdings
MGTX
$1.1B
$92K ﹤0.01%
+8,040
New +$108K
FCN icon
1560
FTI Consulting
FCN
$4.37B
$91K ﹤0.01%
+1,508
New +$87.5K
NCMI icon
1561
National CineMedia
NCMI
$392M
$91K ﹤0.01%
1,084
-5,041
-82% -$342K
SB icon
1562
Safe Bulkers
SB
$803M
$91K ﹤0.01%
+26,627
New +$88.4K
VEON icon
1563
VEON
VEON
$3.68B
$91K ﹤0.01%
1,527
-2,256
-60% -$141K
BAK icon
1564
Braskem
BAK
$924M
$90K ﹤0.01%
+3,460
New +$89.3K
COGT icon
1565
Cogent Biosciences
COGT
$6.64B
$90K ﹤0.01%
+1,568
New +$75.4K
MRNS
1566
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$90K ﹤0.01%
+3,171
New +$70.3K
BKS
1567
DELISTED
Barnes & Noble
BKS
$90K ﹤0.01%
+14,186
New +$80.1K
CYS
1568
DELISTED
CYS Investments Inc.
CYS
$90K ﹤0.01%
12,023
-11,877
-50% -$85K
DSX icon
1569
Diana Shipping
DSX
$311M
$89K ﹤0.01%
26,389
-690
-3% -$2K
EVR icon
1570
Evercore
EVR
$12.3B
$89K ﹤0.01%
840
-16,119
-95% -$1.66M
IMGN
1571
DELISTED
Immunogen Inc
IMGN
$89K ﹤0.01%
9,179
-2,502
-21% -$26.4K
PPC icon
1572
Pilgrim's Pride
PPC
$6.65B
$88K ﹤0.01%
4,350
+2,475
+132% +$53.2K
ASIX icon
1573
AdvanSix
ASIX
$542M
$87K ﹤0.01%
2,379
-6,470
-73% -$243K
LNTH icon
1574
Lantheus
LNTH
$6.59B
$87K ﹤0.01%
6,000
+3,994
+199% +$61.5K
SPWR
1575
DELISTED
SunPower Corporation Common Stock
SPWR
$87K ﹤0.01%
17,408
-9,096
-34% -$49.8K

Similar funds

Cubist Systematic Strategies's Q2 2018 Portfolio in Review

As of Q2 2018, Cubist Systematic Strategies held 2,248 positions worth $1.99B, up 17% from $1.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Cubist Systematic Strategies deployed $258M of net new capital in Q2 2018, opening 441 new positions and adding to 650 existing holdings. Its largest new stake was Sage Therapeutics: 76,110 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $59.2M trimmed.

  • Cubist Systematic Strategies's largest Q2 2018 buy was Sage Therapeutics: 76,110 shares worth $11.9M.
  • Cubist Systematic Strategies added most to ZENDESK INC in Q2 2018, an estimated $10.8M increase.
  • Cubist Systematic Strategies's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $59.2M.
  • Cubist Systematic Strategies fully exited TJX Companies in Q2 2018, selling an estimated $6.46M.
  • Cubist Systematic Strategies's ten largest holdings make up 13% of its $1.99B portfolio in Q2 2018.
  • Cubist Systematic Strategies opened 441 new positions and closed 492 in Q2 2018.
  • Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $1.99B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2018, filed 14 Aug 2018.